Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure
D. Moertl, R. Berger, M. Huelsmann, A. Bojic, and R. Pacher Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure Eur J Heart Fail 7 2005 1156 1163
The Ca(2+)-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine
C. Avgeropoulou, I. Andreadou, and S. Markantonis-Kyroudis The Ca(2+)-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine Eur J Heart Fail 7 5 2005 (Aug.) 882 887
Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients
S. Kyrzopoulos, S. Adamopoulos, and J.T. Parissis Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients Int J Cardiol 99 3 2005 (Mar 30) 409 413
Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure
M. Gwechenberger, M. Hulsmann, and R. Berger Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure Heart Lung Transplant 23 7 2004 (Jul) 839 844
Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase
K.K. Ma, T. Ogawa, and A.J. de Bold Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase J Mol Cell Cardiol 36 4 2004 (Apr.) 505 513
Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery
T. Kawamura, N. Nara, M. Kadosaki, K. Inada, and S. Endo Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery Crit Care Med 28 7 2000 (Jul.) 2201 2208